Related Experiment Videos
A case of giant cell interstitial pneumonia
1Pulmonary Division, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Journal of UOEH
|March 1, 1989
Summary
Giant cell interstitial pneumonia (GIP) is a rare lung disease. This case report details a successful corticosteroid treatment for GIP diagnosed via transbronchial lung biopsy.
Area of Science:
- Pulmonology
- Pathology
- Internal Medicine
Background:
- Giant cell interstitial pneumonia (GIP) is a rare interstitial lung disease.
- Diagnosis often requires lung biopsy.
- Etiology can be idiopathic or related to environmental exposures.
Observation:
- A 61-year-old male presented with cough and dyspnea.
- Chest X-ray revealed diffuse reticular opacities.
- Transbronchial lung biopsy (TBLB) showed multinucleated giant cells with varied morphology.
- Bronchoalveolar lavage fluid also contained numerous giant cells and lymphocytes.
Findings:
- Microscopic examination of TBLB confirmed giant cell interstitial pneumonia.
- Measles pneumonia was excluded based on serology and absence of inclusion bodies.
- No history of heavy metal or organic dust exposure was reported.
- The patient showed significant clinical improvement with corticosteroid therapy.
Implications:
- Corticosteroids can be an effective treatment for GIP.
- TBLB is a valuable diagnostic tool for GIP.
- Further research is needed to understand the pathogenesis and identify potential triggers of GIP.